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Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6 S3pain and improve joint function in patients with end-stage post-trau-
matic OA. This result, combined with the observation that chon-
droprogenitor cells are active in osteoarthritic joints, suggests that
altered loading creates an environment that promotes beneﬁcial joint
remodeling.
Conclusions: Taken together, these recent advances in understanding
of how mechanical forces cause loss of articular cartilage, including
identiﬁcation of mechanically induced mediators of cartilage loss, and
of how changing joint loading can promote joint remodeling provide
the basis for new biologic andmechanical approaches to the prevention
and treatment of all forms of OA.
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RESEARCH TOOLS FOR THE STUDY OF ASPECTS OF THE EPIGENETICS
OF OSTEOARTHRITIS
I.M. Clark. Univ. of East Anglia, Norwich, United Kingdom
Osteoarthritis (OA) is a degenerative joint disease characterised by
degradation of articular cartilage as well as thickening of the sub-
chondral bone and the formation of osteophytes at the joint margin. The
aetiology of OA is complex with genetic, developmental, biochemical
and biomechanical factors contributing to the disease process. Aberrant
gene expression has clearly been shown in OA and epigenetic mecha-
nisms may contribute to this. Epigenetic modiﬁcations may include:
DNA methylation, histone modiﬁcations and non-coding RNA expres-
sion (both microRNA and long non-coding RNA). A number of studies
have compared epigenetic modiﬁcations in OA and normal tissues and
examined epigenetic mechanisms which impact upon the disease. Key
to dissecting the function of epigenetics in OA is the methodology by
which these changes can be measured. This workshop will explore
aspects of the research tools which can be used for the study of epi-
genetics in OA. It will discuss tools which are appropriate in either the
culture ﬂask, or in limiting tissue samples. The scale of the study is also
important since measuring genome wide changes requires different
approaches from determining a single epigenetic mark. Quantiﬁcation
may also be key where different technologies show degrees of accuracy
or linearity which may alter conclusions or require further validation.
The workshop is not a lecture on epigenetics and OA, but rather a dis-
cussion of the tools available for researchers to apply in this area and
their strengths and weaknesses.
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USING ZEBRAFISH TO PROBE THE GENETICS OF OSTEOARTHRITIS
L.H. Brunt y, J. Norton y, S. Reynolds y, E. Moro z, A. Hayes x, E. Rayﬁeld y,
C.L. Hammond y. yUniv. of Bristol, Bristol, United Kingdom; zUniv. of
Padova, Padova, Italy; xUniv. of Cardiff, Cardiff, United Kingdom
Purpose: The purpose of our work is to ascertain the extent to which
zebraﬁsh can be used as an animal model to dissect how osteoarthritis
susceptibility genes affect cell behaviour in the formation and main-
tenance of joints.
Methods: Using BAC recombineering we have generated a number of
transgenic lines in which ﬂuorescent reporters are expressed under the
control of promoters linked to cartilage biology, for example Type 2 and
Type X Collagens and Gdf5, as well as reporters for the activity of a
number of signalling pathways including Wnt and Hedgehog; allowing
us to visualise cell behaviour in real time in the translucent ﬁsh. We
have used a number of histological and immunohistochemical methods
along with electron microscopy and microCT to characterise a number
of events in zebraﬁsh cartilage development, joint formation and during
skeletal ageing. We have also generated Finite Element models that
allow us to visualise the biomechanical strains experienced in zebraﬁsh
jaw elements resulting from the action of their associated muscles.
Results: Using a combination of techniques we show that in the
zebraﬁsh normal joint morphogenesis requires muscle action, and
occurs through changes to cell organisation and orientation. We show
using Finite Element Analysis that positions of high biomechanical
strain in the zebraﬁsh joint overlap regions of high Wnt signalling
activity, and show that Wnt signalling is required downstream of
muscle activity for correct joint morphogenesis. We also show that
cartilage in ageing ﬁsh show a number structural and biochemical
changes some of which are reminiscent of those seen in osteoarthritis in
other animal models and in human cartilageConclusions: Taken together we conclude that zebraﬁsh can be a useful
animal model to dissect the role of osteoarthritis susceptibility genes in
the behaviour of chondrocytes during joint development, homeostasis
and ageing in normal and pathological situations.
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PROTEOMICS AND BIOMARKERS IN OSTEOARTHRITIS
A.O. Aliprantis, S. Ritter. Brigham and Women’s Hosp., Boston, MA, United
States
Purpose: The application of modern proteomic techniques to disease
states affords the opportunity to identify deregulated pathways that
contribute to pathogenesis. These discoveries in turn may lead to new
therapeutic targets, as well as “wet” biomarkers that aid in diagnosis,
prognosis and the prediction of treatment responses. Building on the
concept that osteoarthritis (OA) is a disease of all joint structures
(synovium, cartilage and bone), and that synovial ﬂuid (SF) may rep-
resent of synthesis of inputs from these structures, we compared the
proteomic proﬁle of knee joint SF from patients with early and late stage
OA to unaffected controls by 2-dimensional gel electrophoresis and
mass spectrometry. In our recent publication, using this relatively
unbiased approach, 66 proteins were reported as differentially repre-
sented in healthy vs. OA SF (1). Pathway analysis identiﬁed three bio-
logic processes among these proteins: the complement and coagulation
systems and the acute phase response. Interestingly, early and late OA
manifested a very similar proteomic proﬁle. Together, these ﬁndings
suggest the osteoarthritic disease processes involves activation of
inﬂammatory pathways that are well-established by the time patients
are diagnosed. This presentation will explore 1) the relative con-
tribution of joint tissues to the SF OA proteome, including cartilage and
synovium, 2) how proteomics can illuminate the pathogenesis of OA to
identify therapeutic targets, 3) validation of proteomic discovery ﬁnd-
ings using multiplexed selected reaction monitoring (SRM) mass
spectrometry peptide assays and 4) translation of SF protein biomarkers
to quantitative serum based assays to predict disease progression in OA
patients. At the end of this presentation, attendees should understand
some of the major protein constituents of OA SF and how knowledge of
this proteome may inform pathogenesis and biomarker development
for this difﬁcult disease.
1. Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B,
Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB,
Goldring SR, Lee DM, Gobezie R, and Aliprantis AO. Proteomic
analysis of synovial ﬂuid from the osteoarthritic knee: com-
parison with transcriptome analyses of joint tissues. Arthritis
Rheum 2013;65:981–992.
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HOW LIFESTYLE FACTORS INFLUENCE THE DEVELOPMENT AND
PROGRESSION OF OA
D. Dunlop. Northwestern Univ., Chicago, IL, United States
Purpose: Osteoarthritis (OA) is the most commonworldwide disease of
joints and its prevalence is growing. The worldwide obesity epidemic in
older adults is fueling an increase in many chronic diseases, including
osteoarthritis. This presentation will focus on knee OA, which is the
most prevalent form of OA and a major cause of arthritis-related
functional loss and disability.
The American College of Rheumatology 2012 recommendations rec-
ognize lifestyle factors, including weight loss and physical activity, as
primary nonpharmacologic therapies for OA. Obesity has long been a
recognized risk factor for the development of knee OA. Obesity con-
tributes to OA through joint load, altered gait, and impaired muscle
performance. Importantly weight inﬂuences the course of disease
progression. Longitudinal cohort data provide evidence for a dose
response relationship between weight change and function. Notably,
45% of adults with a weight loss 10% had a clinically meaningful
improvement in WOMAC function. Randomized controlled clinical tri-
als (RCT) support the effectiveness of weight loss to improve function in
adults with knee OA. RCT evidence in obese knee OA patients demon-
strated a 10% weight loss% could improve self-reported function by
more than 25%.
